Publication | Open Access
Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]
172
Citations
43
References
2006
Year
The results suggest that, in early breast cancer, MUC1 immunotherapy is beneficial, and that a larger phase III study should be undertaken.
| Year | Citations | |
|---|---|---|
Page 1
Page 1